Hereditary Papillary Renal Cell Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-03
Clinical Trial Update: Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours [Phase 1]
Phase 1 trial assessing safety and pharmacokinetics of DO-2 in adults with advanced solid tumors, including non-small cell lung cancer and h…